Sloan Sheldon
- SEC CIK
- 0002038798
In the past year, 4 open-market sale filings worth $7.35M and no purchases.
Current role at each company
- SYRE Spyre Therapeutics, Inc.Chief Medical Officeras of Jul 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.35M
- 4 filings
- Net
- −$7.35M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Sloan Sheldon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 (view filing)9:33 PM ET | Jul 1 | 1 day | Sloan SheldonChief Medical Officer | SSale | −8.33K | $87.70 | −$730.9K | −100.0%0 after | 2 lots10b5-1 |
| Jun 3, 2026 (view filing) | Jun 3 | Same day | Sloan SheldonChief Medical Officer | SSale | −8.33K | $75.00 | −$625.0K | −100.0%0 after | 10b5-1 |
| May 1, 2026 (view filing) | May 1 | Same day | Sloan SheldonChief Medical Officer | SSale | −78.3K | $71.50 | −$5.60M | −100.0%0 after | 7 lots10b5-1 |
| Apr 3, 2026 (view filing) | Apr 1 | 2 days | Sloan SheldonChief Medical Officer | SSale | −7.96K | $50.00 | −$397.9K | −100.0%0 after | 10b5-1 |